Prognostic value of CD44 isoform expression in thymic epithelial neoplasms

Cancer

Volumn 103, Issue 10, 2005, Pages 2015-2022

  Sonobe, Satoshi ^a   Miyamoto, Hideaki ^a   Nobukawa, Bunsei ^a   Izumi, Hiroshi ^a   Futagawa, Toshiro ^a   Ishikawa, Noboru ^a   Yamazaki, Akio ^a   Uekusa, Toshimasa ^b   Abe, Hiroshi ^a   Suda, Koichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b KANTO ROSAI HOSPITAL   (Japan)

Author keywords

CD44v6; Immunohistochemistry; Masaoka staging system; Thymic epithelial tumor; World Health Organization histologic classification

Indexed keywords

CD44V ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; EPITHELIUM TUMOR; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; MAJOR CLINICAL STUDY; MALE; MASAOKA STAGING SYSTEM; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; THYMIC EPITHELIAL TUMOR; THYMOMA; TUMOR GROWTH;

ADULT; AGED; ANTIGENS, CD44; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; PROGNOSIS; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 18044380673     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21046     Document Type: Article

References (16)

1. Rosai J, Levine GD. Tumors of the thymus. Atlas of tumor pathology. 2nd series. Fascicle 13. Washington, DC: Armed Forces Institute of Pathology, 1976.
2. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485-2492.
3. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335.
4. Rosai J, Sobin LH. Histological typing of tumors of the thymus. International histological classification of tumors. 2nd edition. New York: Springer-Verlag, 1999.
5. Rios A, Torres J, Galindo PJ, et al. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg. 2002;21:307-313.
6. Gawrychowski J, Rokicki M, Gabriel A, et al. Thymoma-the usefulness of some prognostic factors for diagnosis and surgical treatment. Eur J Surg Oncol. 2000;26:203-208.
7. Lardinois D, Rechsteiner R, Lang RH, et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg. 2000;69:1550-1555.
8. Matsushima S, Yamamoto H, Egami K, et al. Evaluation of the prognostic factors after thymoma resection. Int Surg. 2001;86:103-106.
9. Gripp S, Hilgers K, Wurm R, et al. Thymoma: prognostic factors and treatment outcomes. Cancer. 1998;83:1495-1503.
10. Okumura M, Miyoshi S, Takeuchi Y, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg. 1999;117:605-613.
11. Quintanilla-Martinez L, Wilkins EW, Choi N, et al. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer. 1994;74:606-617.
12. Pescarmona E, Rendina EA, Venuta F, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg. 1990;50:534-538.
13. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60:908-914.
14. Schneider PM, Fellbaum C, Fink U, et al. Prognostic importance of histomorphologic subclassification for epithelial thymic tumors. Ann Surg Oncol. 1997;4:46-56.
15. Gunthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65:13-24.
16. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002;94:624-632.